Andrew Lee

Andrew Lee has a diverse work experience in the biotechnology industry. Andrew is currently working as a Principal at Northpond Ventures, a venture capital firm focused on life science investments. In this role, they are actively involved in supporting and leading investments in various life science companies.

Additionally, Andrew serves as a Board Director at EnPlusOne Biosciences, Culture Biosciences, and Slingshot Biosciences. Andrew provides strategic guidance and oversight to these companies, which are involved in areas such as bioprocess development, synthetic cell manufacturing, and advanced diagnostics.

Andrew also serves as a Board Observer at Refeyn, Ansa Biotechnologies, Sound Agriculture, 64x Bio, Sherlock Biosciences, and Isolere Bio. These companies are involved in different aspects of the biotechnology industry, including analytical instrumentation, DNA manufacturing, agricultural technology, and diagnostic testing.

Overall, Andrew Lee's work experience reflects their deep involvement and passion for the advancement of biotechnology and life sciences. Andrew has contributed to various companies in different capacities, ranging from investment leadership to strategic advisory roles.

Andrew Lee completed their education in a chronological manner. Andrew first attended the University of California, Berkeley from 2005 to 2009 where they earned a Bachelor's Degree in Biochemistry and Molecular Biology. Following this, they pursued a Doctor of Philosophy (Ph.D.) in Microbiology from Columbia University, which they obtained between 2010 and 2016.